Mark A. Dawson

19.3k citations
88 papers · 7.7k · 6 hit papers · h-index 33

Impact in

  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research
  • Genetics top 1%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Epigenetics and DNA Methylation 20
    • Protein Degradation and Inhibitors 16
    • Histone Deacetylase Inhibitors Research 11
    • Genomics and Chromatin Dynamics 9
    • Acute Myeloid Leukemia Research 14

Mark A. Dawson

80 papers receiving 7.6k citations

Mark A. Dawson's Hit Papers

Non-genetic mechanisms of therapeutic resistance in cancer 2020 · 376 citations
3760+5+11Years since publication50010001.5k2.0k

Peers

Mark A. Dawson
Comparison fields: 5 of 143
  • Hematology 1.1k
  • Genetics 795
  • Molecular Biology 5.5k
  • Cancer Research 1.1k
  • Oncology 1.2k
Replace Peter Atadja with:
Peter Atadja United States
Jun Qi United States
Edward A. Fox United States
Domenico Delia Italy
Dan Grandér Sweden
Henrik Daub Germany
Kathleen M. Sakamoto United States
Donald L. Durden United States
Yutaka Kondo Japan
Isidro Sánchez-Garcı́a Spain
Mark A. Dawson relative to Peter Atadja United States Peter Atadja's profile →
Citations per field
00.5×3.4×
Peter Atadja · 1×
Citations per year

Countries citing papers authored by Mark A. Dawson

Since Specialization
Citations

This map shows the geographic impact of Mark A. Dawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Dawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Dawson more than expected).

Fields of papers citing papers by Mark A. Dawson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Dawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Dawson. The network helps show where Mark A. Dawson may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. Dawson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Dawson Line = papers co-authored together Mark A. Dawson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cancer Epigenetics: From Mechanism to Therapy
Hit paper breakdown →
20122386
2
Targeting the epigenetic regulation of antitumour immunity
Hit paper breakdown →
2020487
3
JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin
Hit paper breakdown →
2009451
4
The roles of DNA, RNA and histone methylation in ageing and cancer
Hit paper breakdown →
2019394
5 2013390
6
Non-genetic mechanisms of therapeutic resistance in cancer
Hit paper breakdown →
2020376
7 2012293
8
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
Hit paper breakdown →
2018279
9 2017255
10 2015230
11 2009212
12 2010104
13 2009101
14 199996
15 200992
16 202091
17 201887
18 202185
19 200778
20 201675

About Mark A. Dawson

Mark A. Dawson is a scholar working on Molecular Biology, Hematology, Genetics, Oncology and Pathology and Forensic Medicine, having authored 88 papers that have together received 7.7k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (20 papers), Protein Degradation and Inhibitors (16 papers), Acute Myeloid Leukemia Research (14 papers), Histone Deacetylase Inhibitors Research (11 papers), Cancer Genomics and Diagnostics (10 papers), Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Genomics and Chromatin Dynamics (9 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (795 citations), Molecular Biology (5.5k citations), Cancer Research (1.1k citations) and Oncology (1.2k citations). Mark A. Dawson has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Tony Kouzarides, Andrew J. Bannister, Sarah‐Jane Dawson, Jean‐Christophe Marine, Ricky W. Johnstone, Berthold Göttgens, Paul A. Beavis, Simon J. Hogg, Brian J.P. Huntly and Anthony R. Green. Their work appears in journals such as Blood, Haematologica, Nature Communications, Experimental Hematology and Nature Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact